InvestorsHub Logo
icon url

hutschi

06/05/15 6:53 AM

#222359 RE: atonewith PPHM #222357

NSCLC (Part1)
Immunonkology (I-O) with checkpoint-inhibition: Rovolution of NSCLC-Therapy?

Slide #1